Biological Products, (No Diagnostic Substances)·MAINZ, 2M
Prospectuses & Registrations
33 shown
Filed
Form
Description
11/14/25
424B3
424B3
→
10/21/25
F-4/A
F-4/A
→
9/8/25
F-4/A
F-4/A
→
8/11/25
F-4
F-4
→
2/15/24
S-8
S-8
→
2/13/23
S-8
S-8
→
↓
Ownership
21 shown
Filed
Form
Description
3/18/26
3
3
→
3/18/26
3
3
→
3/18/26
3
3
→
3/18/26
3
3
→
3/18/26
3
3
→
3/18/26
3
3
→
↓
Other Filings
40 shown
Filed
Form
Description
3/11/26
144
144
→
2/12/26
144
144
→
12/18/25
SC TO-T/A
SC TO-T/A
→
12/3/25
SC TO-T/A
SC TO-T/A
→
12/3/25
425
425
→
11/28/25
144
144
→
↓
Filing History(522 filings)
TypeDateAccessionPeriodSize
3
Mar 18, 2026
0001193125-26-1144413
Mar 18, 2026
35.8 KB
3
Mar 18, 2026
0001193125-26-1144333
Mar 18, 2026
49.0 KB
3
Mar 18, 2026
0001193125-26-1144233
Mar 18, 2026
36.7 KB
3
Mar 18, 2026
0001193125-26-1144103
Mar 18, 2026
47.9 KB
3
Mar 18, 2026
0001193125-26-1143983
Mar 18, 2026
37.7 KB
3
Mar 18, 2026
0001193125-26-1143823
Mar 18, 2026
42.1 KB
144
Mar 11, 2026
0002085929-26-000004
—
5.0 KB
20-F
Mar 10, 2026
0001776985-26-00001720-F
Dec 31, 2025
46.1 MB
6-K
Mar 10, 2026
0001776985-26-0000166-K
Mar 10, 2026
5.0 MB
6-K
Mar 10, 2026
0001776985-26-0000156-K
Mar 10, 2026
175.9 KB
144
Feb 12, 2026
0002056296-26-000002
—
10.9 KB
6-K
Jan 28, 2026
0001776985-26-0000076-K
Jan 28, 2026
170.0 KB
6-K
Jan 14, 2026
0001776985-26-0000056-K
Jan 13, 2026
5.2 MB
6-K
Jan 12, 2026
0001776985-26-0000026-K
Jan 12, 2026
141.5 KB
6-K
Jan 6, 2026
0001193125-26-0033926-K
Jan 6, 2026
100.4 KB
SC TO-T/A
Dec 18, 2025
0001193125-25-324846SC TO-T/A
—
21.7 KB
6-K
Dec 18, 2025
0001193125-25-3248416-K
Dec 18, 2025
32.1 KB
6-K
Dec 9, 2025
0001776985-25-0000716-K
Dec 9, 2025
311.4 KB
6-K
Dec 8, 2025
0001776985-25-0000696-K
Dec 6, 2025
87.0 KB
SC TO-T/A
Dec 3, 2025
0001193125-25-306859SC TO-T/A
—
24.1 KB
425
Dec 3, 2025
0001193125-25-306796425
—
43.9 KB
6-K
Dec 3, 2025
0001193125-25-3067906-K
Dec 3, 2025
41.9 KB
144
Nov 28, 2025
0002056296-25-000018
—
10.7 KB
SC TO-T/A
Nov 26, 2025
0001193125-25-300729SC TO-T/A
—
22.1 KB
425
Nov 26, 2025
0001193125-25-300674425
—
45.5 KB
25 filings shown
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.